MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK)

HKD 5.37

(2.48%)

Market Cap (In HKD)

2.28 Billion

Revenue (In HKD)

248.34 Million

Net Income (In HKD)

-125.01 Million

Avg. Volume

255.43 Thousand

Currency
HKD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.12-6.4
PE
-
EPS
-
Beta Value
0.651
ISIN
CNE100004QN6
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Dr. Pan Zheng
Employee Count
-
Website
https://www.microtechmd.com
Ipo Date
2021-10-19
Details
MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and commercialization of diabetes management medical devices and consumables in the People's Republic of China and internationally. Its products include Equil Patch insulin pump systems, AiDEX continuous glucose monitoring systems, POCT analyzer systems, blood glucose monitoring systems, and closed-loop artificial pancreas. The company is also involved in engineering and technology research experimentation and development activities. MicroTech Medical (Hangzhou) Co., Ltd. was incorporated in 2011 and is headquartered in Hangzhou, the People's Republic of China.

More Stocks